US Patent Issued to AstraZeneca on Sept. 8 for "N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides" (Swedish Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,196, issued on Sept. 8, was assigned to AstraZeneca AB (Sodertalje, Sweden).

"N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides" was invented by Jonas Branalt (Gothenberg, Sweden), Bjorn Holm (Gothenberg, Sweden), Maria Johansson (Gothenberg, Sweden), Olle Karlsson (Gothenberg, Sweden), Daniel Laurent Knerr (Gothenberg, Sweden), Anneli Nordqvist (Gothenberg, Sweden), Robert John Sheppard (Gothenberg, Sweden), Marianne Swanson (Gothenberg, Sweden) and Anna Tomberg (Gothenberg, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds having the structure of Formula (I): and pharmaceutically acceptable salts thereof, wherein X1...